Drug-induced skin ulcer: real-world pharmacovigilance analysis based on the FDA adverse event reporting system

Background Skin ulcer (SU) may increase the risk of systemic infections and have evolved into an important public health problem. However, there is a lack of research specifically on drug-induced SU.